Armata Pharmaceuticals, Inc. Common Stock (ARMP)

Operating Cash Flow (Statement)

-$25.42M

TTM · Period ending: · USD

ARMP logo

ARMP Operating Cash Flow (Statement)

Latest reported-$25.42M
ARMP TTM Cash from Operations (-$8.50M → -$25.42M)
High-resolution chart · PNG

ARMP operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Armata Pharmaceuticals, Inc. Common Stock Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-12,100,000
-12,500,000
-11,500,000
-11,400,000
-11,000,000
-10,400,000
-9,500,000
-9,400,000
-8,700,000
-8,500,000
-8,500,000
-8,100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.